These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Osteoporosis and related risk factors in renal transplant recipients. Ahmadpoor P; Reisi S; Makhdoomi K; Ghafari A; Sepehrvand N; Rahimi E Transplant Proc; 2009 Sep; 41(7):2820-2. PubMed ID: 19765445 [TBL] [Abstract][Full Text] [Related]
8. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method. First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249 [No Abstract] [Full Text] [Related]
9. Cyclosporine therapy in pancreas transplantation. Davidson I; Lu C; Melone D; Risser R Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179 [No Abstract] [Full Text] [Related]
10. One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. El Haggan W; Barthe N; Vendrely B; Chauveau P; Berger F; Aparicio M; Potaux L Transplant Proc; 2002 Aug; 34(5):1817-8. PubMed ID: 12176589 [No Abstract] [Full Text] [Related]
11. Loss of blood pressure circadian rhythm in renal transplant recipients taking cyclosporine. Keitel E; Fuchs FD; Costa CA; Bittar AE; Goldani JC; Garcia VD Transplant Proc; 1997; 29(1-2):222. PubMed ID: 9122970 [No Abstract] [Full Text] [Related]
12. Oxidation of low-density lipoproteins in renal transplant recipients. Cofan F; Zambon D; Rodriguez C; Laguna JC; Vazquez M; Casals E; Torregrosa J; Ros E; Oppenheimer F Transplant Proc; 1999 Sep; 31(6):2333-4. PubMed ID: 10500604 [No Abstract] [Full Text] [Related]
16. Lipid profile in renal transplant recipients under various immunosuppressive regimens. Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821 [No Abstract] [Full Text] [Related]
17. Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy. Kempkes-Koch M; Fobker M; Erren M; August C; Gerhardt U; Suwelack B; Hohage H Transplant Proc; 2001 May; 33(3):2167-9. PubMed ID: 11377489 [No Abstract] [Full Text] [Related]
20. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients. Malyszko J; Malyszko JS; Pawlak K; Konstantynowicz J; Wolczynski S; Kaczmarski M; Mysliwiec M Transplant Proc; 2005 Jun; 37(5):2151-3. PubMed ID: 15964364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]